NIH funding from: National Cancer Institute.
This image shows blood vessels (red), cell nuclei (blue), and human metastatic breast cancer cells (green) in a mouse’s brain, after intravenous administration of experimental nanoparticles that can cross the blood-brain barrier.
The successful launch of mRNA vaccines during the Covid-19 pandemic has not only spurred mRNA-related research across interdisciplinary groups, but also further validated the use of lipid nanoparticles as delivery approaches. This issue’s cover story delves into how the interest around exploring nanotechnology for drug delivery solutions has recently grown.
Also, in this month’s issue, we explore what is on the horizon for eConsent, a popular feature in decentralised clinical trial (DCT) space.
Don’t miss an exclusive interview looking at the progress made in the decade since the first chimeric antigen receptor (CAR)-T therapy was successfully tested in a patient.
Also, this month’s thematic take digs into the varied facets of Environmental, Social and Governance (ESG)-related issues in the pharmaceutical industry.
All this and the latest pharma industry news, comment, and analysis from GlobalData.
Read the latest issue of Pharma Technology Focus for all this and insights, and analysis from the pharmaceutical industry.
You can also subscribe here to receive email notifications when a new issue is available.
Source link
#Magazine #Nanoparticle #drug #delivery #research #boost
